ArticleMaterials today. Bio2026

An engineered exosome-based platform for targeted delivery to endogenous neural stem cells and fate modulation after spinal cord injury.

Qing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.